Come up with a name for your new list and we'll add to it:
ProteoTech raised a round of funding on February 14, 2006. Investors include
The Michael J. Fox Foundation.
ProteoTech is a private drug development company focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of…